Asset profile
Nivolumab
Monoclonal antibody
Approvedregulatory verdict
Evidence outlook
Approved: Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
83 competitors in this universe: 22 direct rivals (same mechanism and indication), 1 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Nivolumab: this drug | Approved | Monoclonal antibody | PD-1 | ||
| Cemiplimab | Approved | Monoclonal antibody | PD-1 | ||
| Opdivo Qvantig | Approved | Monoclonal antibody | PD-1 | ||
| Pembrolizumab | Approved | Monoclonal antibody | PD-1 | ||
| Pembrolizumab Berahyaluronidase Alfa | Approved | Monoclonal antibody | PD-1 | ||
| Retifanlimab | Approved | Monoclonal antibody | PD-1 | ||
| Toripalimab | Approved | Monoclonal antibody | PD-1 | ||
| Abp 234 | Phase 3 | Monoclonal antibody | PD-1 | ||
| Balstilimab | Phase 3 | Monoclonal antibody | PD-1 | ||
| Camrelizumab | Phase 3 | Monoclonal antibody | PD-1 | ||
| Cetrelimab | Phase 3 | Monoclonal antibody | PD-1 | ||
| CT-P51 | Phase 3 | Small molecule | PD-1 | ||
| Dostarlimab | Phase 3 | Monoclonal antibody | PD-1 | ||
| Enlonstobart | Phase 3 | Monoclonal antibody | PD-1 | ||
| MB12 | Phase 3 | Monoclonal antibody | PD-1 | ||
| Penpulimab | Phase 3 | Monoclonal antibody | PD-1 |
…and 68 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
vs Cemiplimab · Non-Small Cell Lung Cancervs Pembrolizumab · Non-Small Cell Lung Cancervs Retifanlimab · Non-Small Cell Lung Cancervs Toripalimab · Non-Small Cell Lung Cancervs Camrelizumab · Non-Small Cell Lung Cancervs Dostarlimab · Non-Small Cell Lung Cancer
16 further head-to-head pairs are tracked; the rosters on each shared mechanism and indication page list every rival in the race.
Upcoming events
(380 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (58)
October 2026 (6)
Phase 1Melanoma, Unresectable Solid Tumors, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Antineoplastic Agents, Immunological …Active not recruiting
Est. primary completion 2026-10-07 · NCT04572451 · CT.gov ↗
What to watch
Phase 2Castration-resistant Prostate Cancer, Metastatic CancerActive not recruiting
Est. primary completion 2026-10-12 · NCT05502315 · CT.gov ↗
What to watch
Phase 1Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma …Recruiting
Est. primary completion 2026-10-19 · NCT06399419 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer, Metastatic Gastroesophageal Adenocarcinoma, DPD DeficiencyRecruiting
Est. primary completion 2026-10-22 · NCT06245356 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorRecruiting
Est. primary completion 2026-10-30 · NCT06302426 · CT.gov ↗
What to watch
Phase 1CancerActive not recruiting
Est. primary completion 2026-10-31 · NCT04336241 · CT.gov ↗
What to watch
November 2026 (9)
Phase 2Melanoma, Brain MetastasesRecruiting
Est. primary completion 2026-11 · NCT06712927 · CT.gov ↗
What to watch
Phase 2GlioblastomaActive not recruiting
Est. primary completion 2026-11 · NCT03743662 · CT.gov ↗
What to watch
Phase 1/2Renal Cell CarcinomaActive not recruiting
Est. primary completion 2026-11-01 · NCT05501054 · CT.gov ↗
What to watch
Phase 2Renal Cell CarcinomaRecruiting
Est. primary completion 2026-11-01 · NCT06053658 · CT.gov ↗
What to watch
Phase 1Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Indolent Non-Hodgkin Lymphoma …Active not recruiting
Est. primary completion 2026-11-04 · NCT03884998 · CT.gov ↗
What to watch
Phase 1/2Renal Cell CarcinomaActive not recruiting
Est. primary completion 2026-11-06 · NCT03172754 · CT.gov ↗
What to watch
Phase 1/2GlioblastomaActive not recruiting
Est. primary completion 2026-11-17 · NCT03233152 · CT.gov ↗
What to watch
Phase 1/2Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, PD-L1 Positive …Active not recruiting
Est. primary completion 2026-11-25 · NCT02955290 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorActive not recruiting
Est. primary completion 2026-11-30 · NCT04735978 · CT.gov ↗
What to watch
December 2026 (43)
Phase 1Stage IV Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12 · NCT03223155 · CT.gov ↗
What to watch
Phase 1Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal Adenocarcinoma …Recruiting
Est. primary completion 2026-12 · NCT04900818 · CT.gov ↗
What to watch
Phase 1/2Uveal Melanoma, MetastaticActive not recruiting
Est. primary completion 2026-12 · NCT04283890 · CT.gov ↗
What to watch
Phase 1/2Gastroesophageal Cancer, Immune Checkpoint InhibitionActive not recruiting
Est. primary completion 2026-12 · NCT03610711 · CT.gov ↗
What to watch
Phase 1/2Prostate CancerActive not recruiting
Est. primary completion 2026-12 · NCT04989946 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12 · NCT03527108 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaActive not recruiting
Est. primary completion 2026-12 · NCT05476796 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma of the SkinRecruiting
Est. primary completion 2026-12 · NCT04204837 · CT.gov ↗
What to watch
Phase 2Merkel Cell CarcinomaRecruiting
Est. primary completion 2026-12 · NCT06151236 · CT.gov ↗
What to watch
Phase 2Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma, Neuroendocrine Tumors, Carcinoid TumorRecruiting
Est. primary completion 2026-12 · NCT05263050 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer, Colorectal Carcinoma, Liver MetastasesRecruiting
Est. primary completion 2026-12 · NCT04912765 · CT.gov ↗
What to watch
Phase 2Hodgkin LymphomaActive not recruiting
Est. primary completion 2026-12 · NCT05723055 · CT.gov ↗
What to watch
Phase 3Metastatic Colon Cancer, Stage III Colon CancerActive not recruiting
Est. primary completion 2026-12 · NCT03803553 · CT.gov ↗
What to watch
Early phase / not applicableHigh Grade Glioma, Replication Repair DeficientRecruiting
Est. primary completion 2026-12 · NCT06519682 · CT.gov ↗
What to watch
Early phase / not applicableMalignant AscitesEnrolling by invitation
Est. primary completion 2026-12 · NCT05745233 · CT.gov ↗
What to watch
Phase 1Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated LymphomasRecruiting
Est. primary completion 2026-12-01 · NCT04902443 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-01 · NCT06554613 · CT.gov ↗
What to watch
Phase 2Urologic Neoplasms, Urogenital Neoplasms, Neoplasms by Site, Neoplasms, Female Urogenital Diseases …Active not recruiting
Est. primary completion 2026-12-01 · NCT06237920 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma, Muscle-invasive Bladder CancerRecruiting
Est. primary completion 2026-12-01 · NCT06682728 · CT.gov ↗
What to watch
Phase 1Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 …Active not recruiting
Est. primary completion 2026-12-03 · NCT04652960 · CT.gov ↗
What to watch
Phase 2Pleural Biphasic Mesothelioma, Pleural Sarcomatoid MesotheliomaRecruiting
Est. primary completion 2026-12-15 · NCT05647265 · CT.gov ↗
What to watch
Phase 3Non-Clear Cell Renal Cell CarcinomaActive not recruiting
Est. primary completion 2026-12-15 · NCT05678673 · CT.gov ↗
What to watch
Phase 2Papillary Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Translocation Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma …Active not recruiting
Est. primary completion 2026-12-20 · NCT04413123 · CT.gov ↗
What to watch
Phase 1Glioblastoma, GBM, Glioblastoma Multiforme, Grade IV AstrocytomaActive not recruiting
Est. primary completion 2026-12-30 · NCT04606316 · CT.gov ↗
What to watch
Phase 2Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder, Non-urothelial Upper Tract, Penile Cancer …Active not recruiting
Est. primary completion 2026-12-30 · NCT03333616 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Gastric CancerRecruiting
Est. primary completion 2026-12-30 · NCT03259867 · CT.gov ↗
What to watch
Phase 2Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 …Active not recruiting
Est. primary completion 2026-12-30 · NCT03776487 · CT.gov ↗
What to watch
Phase 1Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2026-12-31 · NCT05234307 · CT.gov ↗
What to watch
Phase 1Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage IV Renal Cell Cancer AJCC v7Active not recruiting
Est. primary completion 2026-12-31 · NCT02210117 · CT.gov ↗
What to watch
Phase 1Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT06532344 · CT.gov ↗
What to watch
Phase 1Leptomeningeal DiseaseRecruiting
Est. primary completion 2026-12-31 · NCT05112549 · CT.gov ↗
What to watch
Phase 1MelanomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04835805 · CT.gov ↗
What to watch
Phase 1/2Melanoma, In-Transit MetastasisRecruiting
Est. primary completion 2026-12-31 · NCT03685890 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-31 · NCT05597800 · CT.gov ↗
What to watch
Phase 2Advanced Acral Melanoma, Advanced Cutaneous Melanoma, Advanced Mucosal Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 …Recruiting
Est. primary completion 2026-12-31 · NCT07155317 · CT.gov ↗
What to watch
Phase 2Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid TumorsRecruiting
Est. primary completion 2026-12-31 · NCT03297606 · CT.gov ↗
What to watch
Phase 2Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma …Active not recruiting
Est. primary completion 2026-12-31 · NCT04953104 · CT.gov ↗
What to watch
Phase 2Uterine Cervical NeoplasmsRecruiting
Est. primary completion 2026-12-31 · NCT05492123 · CT.gov ↗
What to watch
Phase 2Rectal Cancer Stage II, Rectal Cancer Stage IIIActive not recruiting
Est. primary completion 2026-12-31 · NCT04503694 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Advanced CancerRecruiting
Est. primary completion 2026-12-31 · NCT05257590 · CT.gov ↗
What to watch
Phase 2Astrocytoma, IDH-Mutant, Grade 4, Diffuse Glioma, Glioblastoma, IDH-Wildtype, Secondary GlioblastomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04145115 · CT.gov ↗
What to watch
Phase 3Primary Mediastinal Large B-Cell LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04759586 · CT.gov ↗
What to watch
2027 (168)
January 2027 (17)
Phase 1/2Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-01 · NCT03033914 · CT.gov ↗
What to watch
Phase 1/2Sarcoma, Solid Tumor, Adult, Solid Tumor, ChildhoodRecruiting
Est. primary completion 2027-01 · NCT03465592 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-01 · NCT05280457 · CT.gov ↗
What to watch
Phase 2Microsatellite Stable Colorectal Cancer, Pancreatic Cancer, MSI High Colorectal CancerActive not recruiting
Est. primary completion 2027-01 · NCT03104439 · CT.gov ↗
What to watch
Phase 2Bladder CancerActive not recruiting
Est. primary completion 2027-01 · NCT03520491 · CT.gov ↗
What to watch
Phase 2Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2027-01-01 · NCT06731270 · CT.gov ↗
What to watch
Phase 2Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IVActive not recruiting
Est. primary completion 2027-01-01 · NCT05788081 · CT.gov ↗
What to watch
Phase 2Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 …Recruiting
Est. primary completion 2027-01-01 · NCT05136196 · CT.gov ↗
What to watch
Phase 1Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma …Active not recruiting
Est. primary completion 2027-01-12 · NCT05122546 · CT.gov ↗
What to watch
Phase 1/2Solid TumorRecruiting
Est. primary completion 2027-01-19 · NCT05584670 · CT.gov ↗
What to watch
Phase 2ICB-refractory MelanomaActive not recruiting
Est. primary completion 2027-01-23 · NCT06250335 · CT.gov ↗
What to watch
Phase 1HER2-Expressing Solid TumorsRecruiting
Est. primary completion 2027-01-31 · NCT07334119 · CT.gov ↗
What to watch
Phase 1Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma, Pleomorphic Rhabdomyosarcoma …Active not recruiting
Est. primary completion 2027-01-31 · NCT04420975 · CT.gov ↗
What to watch
Phase 1Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8Active not recruiting
Est. primary completion 2027-01-31 · NCT03816358 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-01-31 · NCT05176483 · CT.gov ↗
What to watch
Phase 1/2Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 …Recruiting
Est. primary completion 2027-01-31 · NCT05896839 · CT.gov ↗
What to watch
Phase 2Malignant Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IVActive not recruiting
Est. primary completion 2027-01-31 · NCT04079166 · CT.gov ↗
What to watch
February 2027 (14)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT05076760 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT06463665 · CT.gov ↗
What to watch
Phase 2Esophagogastric Cancer, HER2-NegativeActive not recruiting
Est. primary completion 2027-02 · NCT04757363 · CT.gov ↗
What to watch
Phase 1/2Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant Tumors …Active not recruiting
Est. primary completion 2027-02-01 · NCT05407441 · CT.gov ↗
What to watch
Phase 2Metastatic Soft-tissue SarcomaActive not recruiting
Est. primary completion 2027-02-01 · NCT04551430 · CT.gov ↗
What to watch
Phase 1Head and Neck CancerActive not recruiting
Est. primary completion 2027-02-02 · NCT05327270 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-02-05 · NCT06946797 · CT.gov ↗
What to watch
Phase 1GlioblastomaActive not recruiting
Est. primary completion 2027-02-15 · NCT04047706 · CT.gov ↗
What to watch
Phase 2Cutaneous Melanoma, Melanoma Stage IV, Mucosal MelanomaRecruiting
Est. primary completion 2027-02-15 · NCT06319196 · CT.gov ↗
What to watch
Phase 2Classical Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-02-15 · NCT02940301 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-28 · NCT05267626 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-28 · NCT06047379 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-28 · NCT06275360 · CT.gov ↗
What to watch
Phase 2Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Neuroendocrine Carcinoma …Recruiting
Est. primary completion 2027-02-28 · NCT03866382 · CT.gov ↗
What to watch
March 2027 (18)
Phase 1Glioblastoma (GBM), Diffuse Midline Glioma (DMG), Astrocytoma, IDH-Mutant, Grade 4, Diffuse Hemispheric Glioma, H3 G34-Mutant …Enrolling by invitation
Est. primary completion 2027-03 · NCT06896110 · CT.gov ↗
What to watch
Phase 1Gastric Cancer, Esophageal Cancer, GastroEsophageal CancerActive not recruiting
Est. primary completion 2027-03 · NCT03044613 · CT.gov ↗
What to watch
Phase 1/2B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in RelapseRecruiting
Est. primary completion 2027-03 · NCT05310591 · CT.gov ↗
What to watch
Phase 2Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell CarcinomaActive not recruiting
Est. primary completion 2027-03 · NCT05239533 · CT.gov ↗
What to watch
Phase 1NeoplasmsActive not recruiting
Est. primary completion 2027-03-01 · NCT02817633 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Urethra …Recruiting
Est. primary completion 2027-03-01 · NCT06983210 · CT.gov ↗
What to watch
Phase 1Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2027-03-02 · NCT03655002 · CT.gov ↗
What to watch
Phase 1Locally Advanced or Metastatic MelanomaRecruiting
Est. primary completion 2027-03-04 · NCT05498792 · CT.gov ↗
What to watch
Phase 2Melanoma, Melanoma Stage IIIActive not recruiting
Est. primary completion 2027-03-11 · NCT05289193 · CT.gov ↗
What to watch
Phase 3Renal Cell CarcinomaActive not recruiting
Est. primary completion 2027-03-11 · NCT03873402 · CT.gov ↗
What to watch
Phase 1/2Grade 2 Meningioma, Grade 3 Meningioma, Recurrent MeningiomaActive not recruiting
Est. primary completion 2027-03-19 · NCT03604978 · CT.gov ↗
What to watch
Phase 1Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin NeoplasmActive not recruiting
Est. primary completion 2027-03-31 · NCT04387084 · CT.gov ↗
What to watch
Phase 1/2Solid NeoplasmsActive not recruiting
Est. primary completion 2027-03-31 · NCT04078295 · CT.gov ↗
What to watch
Phase 2Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8Recruiting
Est. primary completion 2027-03-31 · NCT06064097 · CT.gov ↗
What to watch
Phase 2Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-03-31 · NCT04310007 · CT.gov ↗
What to watch
Phase 3Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Metastatic Anal Squamous Cell Carcinoma, Recurrent Anal Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2027-03-31 · NCT04444921 · CT.gov ↗
What to watch
Phase 3Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-03-31 · NCT03391869 · CT.gov ↗
What to watch
Early phase / not applicableMetastatic Melanoma, Skin CancerRecruiting
Est. primary completion 2027-03-31 · NCT07422779 · CT.gov ↗
What to watch
April 2027 (18)
Phase 1Melanoma Stage III, Melanoma Stage IV, BRAF V600 MutationRecruiting
Est. primary completion 2027-04 · NCT04741997 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-04 · NCT04848116 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer Metastatic, MSI-H Colorectal CancerActive not recruiting
Est. primary completion 2027-04 · NCT04730544 · CT.gov ↗
What to watch
Phase 2Metastatic MelanomaActive not recruiting
Est. primary completion 2027-04 · NCT03122522 · CT.gov ↗
What to watch
Phase 3Advanced (Unresectable or Metastatic) MelanomaRecruiting
Est. primary completion 2027-04 · NCT07221734 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-04-01 · NCT05254184 · CT.gov ↗
What to watch
Phase 1Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemActive not recruiting
Est. primary completion 2027-04-01 · NCT04609046 · CT.gov ↗
What to watch
Phase 1/2Cancer, Colorectal Cancer, Solid Tumor, Locally Advanced Solid Tumor, Metastatic Cancer, WNT Pathway, HCC, Desmoid …Recruiting
Est. primary completion 2027-04-01 · NCT05919264 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaActive not recruiting
Est. primary completion 2027-04-05 · NCT03097939 · CT.gov ↗
What to watch
Phase 1Clear Cell Renal Cell CarcinomaRecruiting
Est. primary completion 2027-04-07 · NCT07187869 · CT.gov ↗
What to watch
Phase 1Squamous Cell Carcinoma of the Head and NeckActive not recruiting
Est. primary completion 2027-04-09 · NCT03690986 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-04-09 · NCT02393625 · CT.gov ↗
What to watch
Phase 1/2Solid Tumor, Metastases to Soft TissueActive not recruiting
Est. primary completion 2027-04-23 · NCT03707808 · CT.gov ↗
What to watch
Phase 1Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Carcinoma …Active not recruiting
Est. primary completion 2027-04-24 · NCT05802056 · CT.gov ↗
What to watch
Phase 1Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-04-27 · NCT05162976 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-04-27 · NCT06364917 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-04-30 · NCT03589339 · CT.gov ↗
What to watch
Phase 2Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone, Malignancy in Giant Cell Tumor of Bone, Malignant Solid Neoplasm …Active not recruiting
Est. primary completion 2027-04-30 · NCT03449108 · CT.gov ↗
What to watch
May 2027 (9)
Phase 2Kidney Cancer, Renal Cell CarcinomaActive not recruiting
Est. primary completion 2027-05 · NCT04322955 · CT.gov ↗
What to watch
Phase 2Mucosal MelanomaRecruiting
Est. primary completion 2027-05 · NCT05384496 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Resectable Colorectal CarcinomaRecruiting
Est. primary completion 2027-05 · NCT05845450 · CT.gov ↗
What to watch
Phase 2Muscle-Invasive Bladder CarcinomaActive not recruiting
Est. primary completion 2027-05 · NCT04506554 · CT.gov ↗
What to watch
Phase 2Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 …Recruiting
Est. primary completion 2027-05-01 · NCT06265285 · CT.gov ↗
What to watch
Phase 1Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8Active not recruiting
Est. primary completion 2027-05-25 · NCT06049576 · CT.gov ↗
What to watch
Phase 2Premalignant LesionRecruiting
Est. primary completion 2027-05-30 · NCT06561087 · CT.gov ↗
What to watch
Phase 2Metastatic Malignant Solid Neoplasm, Unresectable Solid NeoplasmActive not recruiting
Est. primary completion 2027-05-31 · NCT04957615 · CT.gov ↗
What to watch
Phase 3Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7Active not recruiting
Est. primary completion 2027-05-31 · NCT02595944 · CT.gov ↗
What to watch
June 2027 (18)
Phase 1Gastroesophageal AdenocarcinomaRecruiting
Est. primary completion 2027-06 · NCT05733689 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT05681780 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-06 · NCT06015724 · CT.gov ↗
What to watch
Phase 2Breast CancerActive not recruiting
Est. primary completion 2027-06 · NCT03546686 · CT.gov ↗
What to watch
Phase 2MesotheliomaActive not recruiting
Est. primary completion 2027-06 · NCT03918252 · CT.gov ↗
What to watch
Phase 1Acral Lentiginous Melanoma, Central Nervous System Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Leptomeningeal Neoplasm …Active not recruiting
Est. primary completion 2027-06-01 · NCT03025256 · CT.gov ↗
What to watch
Phase 1Colorectal Cancer, Pancreatic CancerActive not recruiting
Est. primary completion 2027-06-01 · NCT04117087 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06-01 · NCT05317858 · CT.gov ↗
What to watch
Phase 2MelanomaActive not recruiting
Est. primary completion 2027-06-09 · NCT05912244 · CT.gov ↗
What to watch
Phase 1Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma …Recruiting
Est. primary completion 2027-06-28 · NCT05272384 · CT.gov ↗
What to watch
Phase 1/2Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Pancreatic CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT04396821 · CT.gov ↗
What to watch
Phase 1/2Advanced CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT04495296 · CT.gov ↗
What to watch
Phase 1/2Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-06-30 · NCT01896999 · CT.gov ↗
What to watch
Phase 2Metastatic Head-and-neck Squamous-cell CarcinomaActive not recruiting
Est. primary completion 2027-06-30 · NCT04831320 · CT.gov ↗
What to watch
Phase 2Metastatic MelanomaActive not recruiting
Est. primary completion 2027-06-30 · NCT05034536 · CT.gov ↗
What to watch
Phase 2Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin …Active not recruiting
Est. primary completion 2027-06-30 · NCT03505320 · CT.gov ↗
What to watch
Phase 2Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma …Recruiting
Est. primary completion 2027-06-30 · NCT04511013 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8Active not recruiting
Est. primary completion 2027-06-30 · NCT04751370 · CT.gov ↗
What to watch
July 2027 (7)
Phase 2Cancer of RectumRecruiting
Est. primary completion 2027-07 · NCT05732389 · CT.gov ↗
What to watch
Phase 2Basal Cell CarcinomaRecruiting
Est. primary completion 2027-07 · NCT03521830 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-07 · NCT07084610 · CT.gov ↗
What to watch
Phase 2Anal Melanoma, Bladder Melanoma, Cervical Melanoma, Esophageal Melanoma, Gallbladder Melanoma, Head and Neck Mucosal Melanoma …Active not recruiting
Est. primary completion 2027-07-15 · NCT05111574 · CT.gov ↗
What to watch
Phase 2Carcinomas, Renal Medullary CarcinomaActive not recruiting
Est. primary completion 2027-07-16 · NCT05347212 · CT.gov ↗
What to watch
Phase 1/2STOMACH NEOPLASM, Gastric Cancer, Gastric Cancer Adenocarcinoma MetastaticRecruiting
Est. primary completion 2027-07-30 · NCT07149090 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma, Bladder CancerActive not recruiting
Est. primary completion 2027-07-31 · NCT02845323 · CT.gov ↗
What to watch
August 2027 (10)
Phase 1Melanoma (Skin)Active not recruiting
Est. primary completion 2027-08 · NCT06377111 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or PembrolizumabRecruiting
Est. primary completion 2027-08 · NCT05901285 · CT.gov ↗
What to watch
Phase 2Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma …Active not recruiting
Est. primary completion 2027-08 · NCT03635892 · CT.gov ↗
What to watch
Phase 3Squamous Cell Carcinoma of Head and NeckActive not recruiting
Est. primary completion 2027-08 · NCT03576417 · CT.gov ↗
What to watch
Phase 1Lymphoma, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Unresectable Malignant Solid NeoplasmActive not recruiting
Est. primary completion 2027-08-01 · NCT03502733 · CT.gov ↗
What to watch
Phase 1Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-08-01 · NCT07075120 · CT.gov ↗
What to watch
Phase 2Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma …Recruiting
Est. primary completion 2027-08-03 · NCT04745949 · CT.gov ↗
What to watch
Phase 1MelanomaNot yet recruiting
Est. primary completion 2027-08-16 · NCT07476326 · CT.gov ↗
What to watch
Phase 2Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter SyndromeActive not recruiting
Est. primary completion 2027-08-24 · NCT05672173 · CT.gov ↗
What to watch
September 2027 (11)
Phase 2Esophageal Cancer, Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-09 · NCT07152678 · CT.gov ↗
What to watch
Phase 2Cancer, Tumors, Neoplasm, NeoplasiaRecruiting
Est. primary completion 2027-09 · NCT02925234 · CT.gov ↗
What to watch
Phase 2Gastric CancerRecruiting
Est. primary completion 2027-09 · NCT06253611 · CT.gov ↗
What to watch
Phase 2SARCOMAActive not recruiting
Est. primary completion 2027-09 · NCT03282344 · CT.gov ↗
What to watch
Phase 2Advanced or Metastatic Gastrooesophageal CarcinomaRecruiting
Est. primary completion 2027-09 · NCT07213557 · CT.gov ↗
What to watch
Phase 3Malignant Melanoma Stage IIActive not recruiting
Est. primary completion 2027-09 · NCT04309409 · CT.gov ↗
What to watch
Phase 2Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Apocrine Carcinoma …Active not recruiting
Est. primary completion 2027-09-01 · NCT02978625 · CT.gov ↗
What to watch
Phase 1Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT06532331 · CT.gov ↗
What to watch
Phase 1Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8 …Recruiting
Est. primary completion 2027-09-30 · NCT04697576 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT04884282 · CT.gov ↗
What to watch
Phase 2Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic SyndromeActive not recruiting
Est. primary completion 2027-09-30 · NCT02530463 · CT.gov ↗
What to watch
October 2027 (13)
Phase 2Metastatic Cancer, Melanoma Cancer, Lung Cancer, Bladder Cancer, Renal Cancer, Head/Neck CancersActive not recruiting
Est. primary completion 2027-10 · NCT03693014 · CT.gov ↗
What to watch
Phase 2Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 …Recruiting
Est. primary completion 2027-10-01 · NCT05361720 · CT.gov ↗
What to watch
Phase 3Solid Tumor MalignanciesRecruiting
Est. primary completion 2027-10-01 · NCT07174453 · CT.gov ↗
What to watch
Phase 2Relapsed Classic Hodgkin LymphomaRecruiting
Est. primary completion 2027-10-02 · NCT04561206 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorsActive not recruiting
Est. primary completion 2027-10-14 · NCT06544655 · CT.gov ↗
What to watch
Phase 1Advanced Malignant TumorsRecruiting
Est. primary completion 2027-10-15 · NCT06764771 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-10-15 · NCT05012254 · CT.gov ↗
What to watch
Phase 3Advanced MelanomaRecruiting
Est. primary completion 2027-10-16 · NCT06112314 · CT.gov ↗
What to watch
Phase 1/2Advanced Cancer, Clear Cell Renal Cell CarcinomaRecruiting
Est. primary completion 2027-10-30 · NCT05663710 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-10-31 · NCT07376707 · CT.gov ↗
What to watch
Phase 1Colorectal CancerActive not recruiting
Est. primary completion 2027-10-31 · NCT06547385 · CT.gov ↗
What to watch
Phase 2Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma …Active not recruiting
Est. primary completion 2027-10-31 · NCT03307616 · CT.gov ↗
What to watch
Phase 2/3Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma …Recruiting
Est. primary completion 2027-10-31 · NCT06203600 · CT.gov ↗
What to watch
November 2027 (9)
Phase 1Metastatic Renal Cell Carcinoma, Brain MetastasesActive not recruiting
Est. primary completion 2027-11 · NCT06132945 · CT.gov ↗
What to watch
Phase 1Malignant Pleural MesotheliomaActive not recruiting
Est. primary completion 2027-11 · NCT04162015 · CT.gov ↗
What to watch
Phase 2Leptomeningeal MetastasisRecruiting
Est. primary completion 2027-11 · NCT06901817 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-11 · NCT03406247 · CT.gov ↗
What to watch
Phase 1Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Cutaneous Melanoma …Recruiting
Est. primary completion 2027-11-01 · NCT05098210 · CT.gov ↗
What to watch
Phase 2Muscle-invasive Urothelial CarcinomaActive not recruiting
Est. primary completion 2027-11-10 · NCT06534983 · CT.gov ↗
What to watch
Phase 1Phase 1b, HC-7366, SHARK, Kidney CancerRecruiting
Est. primary completion 2027-11-30 · NCT07401875 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-11-30 · NCT03838159 · CT.gov ↗
What to watch
Phase 2Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin LymphomaRecruiting
Est. primary completion 2027-11-30 · NCT05039073 · CT.gov ↗
What to watch
December 2027 (24)
Phase 1/2Solid Tumor, MelanomaRecruiting
Est. primary completion 2027-12 · NCT05423262 · CT.gov ↗
What to watch
Phase 2Esophageal Adenocarcinoma, Gastric AdenocarcinomaRecruiting
Est. primary completion 2027-12 · NCT04150640 · CT.gov ↗
What to watch
Phase 2Cutaneous Melanoma, Stage III, Mucosal MelanomaRecruiting
Est. primary completion 2027-12 · NCT07230613 · CT.gov ↗
What to watch
Phase 2Hodgkin Lymphoma, Hodgkin Disease, Advanced Hodgkin LymphomaRecruiting
Est. primary completion 2027-12 · NCT07209059 · CT.gov ↗
What to watch
Phase 1Cervical CarcinomaRecruiting
Est. primary completion 2027-12-01 · NCT07653503 · CT.gov ↗
What to watch
Phase 2Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 …Active not recruiting
Est. primary completion 2027-12-08 · NCT02910700 · CT.gov ↗
What to watch
Phase 1/2BRAF NP_004324.2:p.V600E, Metastatic Colon Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma …Active not recruiting
Est. primary completion 2027-12-30 · NCT04017650 · CT.gov ↗
What to watch
Phase 2BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma, Refractory Thyroid Gland Carcinoma …Active not recruiting
Est. primary completion 2027-12-30 · NCT04061980 · CT.gov ↗
What to watch
Phase 1Unresectable Colorectal CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT06540261 · CT.gov ↗
What to watch
Phase 1Melanoma, Metastatic MelanomaActive not recruiting
Est. primary completion 2027-12-31 · NCT04930783 · CT.gov ↗
What to watch
Phase 1ALK Gene Rearrangement, EGFR Gene Mutation, Locally Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma …Active not recruiting
Est. primary completion 2027-12-31 · NCT04013542 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12-31 · NCT06362369 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT02696993 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT04165330 · CT.gov ↗
What to watch
Phase 1/2Recurrent Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV, Melanoma Stage IIIRecruiting
Est. primary completion 2027-12-31 · NCT05655312 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-12-31 · NCT04729322 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma …Active not recruiting
Est. primary completion 2027-12-31 · NCT04940299 · CT.gov ↗
What to watch
Phase 2Brain Metastases, Renal Cell CarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT05048212 · CT.gov ↗
What to watch
Phase 2Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Clear Cell Renal Cell CarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT06863311 · CT.gov ↗
What to watch
Phase 2Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Bladder Carcinoma, Breast Carcinoma, Cervical Carcinoma, Colon Carcinoma …Active not recruiting
Est. primary completion 2027-12-31 · NCT02465060 · CT.gov ↗
What to watch
Phase 2Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid TumorsRecruiting
Est. primary completion 2027-12-31 · NCT02693535 · CT.gov ↗
What to watch
Phase 3Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma, Stage IIB Anal Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-12-31 · NCT03233711 · CT.gov ↗
What to watch
Early phase / not applicableMetastatic MelanomaRecruiting
Est. primary completion 2027-12-31 · NCT07564570 · CT.gov ↗
What to watch
2028 (56)
January 2028 (5)
Phase 2Hodgkin Lymphoma, AdultRecruiting
Est. primary completion 2028-01 · NCT06984146 · CT.gov ↗
What to watch
Phase 2Metastatic Melanoma, Skin CancerRecruiting
Est. primary completion 2028-01-01 · NCT05779423 · CT.gov ↗
What to watch
Phase 3MelanomaActive not recruiting
Est. primary completion 2028-01-25 · NCT06054555 · CT.gov ↗
What to watch
Phase 3Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes …Active not recruiting
Est. primary completion 2028-01-25 · NCT03793166 · CT.gov ↗
What to watch
Phase 2Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell AdenocarcinomaActive not recruiting
Est. primary completion 2028-01-31 · NCT05504252 · CT.gov ↗
What to watch
February 2028 (3)
Phase 2Colorectal CancerRecruiting
Est. primary completion 2028-02-15 · NCT06948448 · CT.gov ↗
What to watch
Phase 1Solid Tumor, Locally Advanced Solid Tumor, Metastatic TumorRecruiting
Est. primary completion 2028-02-28 · NCT07404332 · CT.gov ↗
What to watch
Phase 1/2Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8 …Recruiting
Est. primary completion 2028-02-28 · NCT04380545 · CT.gov ↗
What to watch
March 2028 (6)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-03 · NCT06800339 · CT.gov ↗
What to watch
Phase 1Advanced or Metastatic Solid TumorsActive not recruiting
Est. primary completion 2028-03 · NCT03155061 · CT.gov ↗
What to watch
Phase 2Cutaneous Melanoma, Mucosal MelanomaRecruiting
Est. primary completion 2028-03 · NCT06999980 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-03-01 · NCT05684276 · CT.gov ↗
What to watch
Phase 1Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm, Inflammatory Bowel Disease …Recruiting
Est. primary completion 2028-03-30 · NCT03816345 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Gastric CancerEnrolling by invitation
Est. primary completion 2028-03-30 · NCT07542262 · CT.gov ↗
What to watch
April 2028 (5)
Phase 4Kidney Cancer, Renal Cell CancerRecruiting
Est. primary completion 2028-04 · NCT06934057 · CT.gov ↗
What to watch
Phase 3Extensive-Stage Small Cell Lung CancerRecruiting
Est. primary completion 2028-04-06 · NCT06646276 · CT.gov ↗
What to watch
Phase 2Recurrent/ Metastatic Olfactory NeuroblastomaRecruiting
Est. primary completion 2028-04-14 · NCT07100704 · CT.gov ↗
What to watch
Phase 1/2Solid Tumor, AdultActive not recruiting
Est. primary completion 2028-04-30 · NCT04725474 · CT.gov ↗
What to watch
May 2028 (2)
Phase 2Basal Cell CarcinomaRecruiting
Est. primary completion 2028-05 · NCT06624475 · CT.gov ↗
What to watch
Phase 1CNS Malignancies, Medulloblastoma Recurrent, ATRT Recurrent, Pineoblastoma, Embryonal Neoplasm, Ependymoma Recurrent, High Grade GliomasRecruiting
Est. primary completion 2028-05-01 · NCT07017816 · CT.gov ↗
What to watch
June 2028 (10)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-06 · NCT03767348 · CT.gov ↗
What to watch
Phase 2Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2028-06-01 · NCT03080974 · CT.gov ↗
What to watch
Phase 2Hepato Cellular Carcinoma (HCC), Renal Cell CancerNot yet recruiting
Est. primary completion 2028-06-01 · NCT07494435 · CT.gov ↗
What to watch
Phase 2Locally Advanced Renal Cell CarcinomaRecruiting
Est. primary completion 2028-06-06 · NCT06794229 · CT.gov ↗
What to watch
Phase 2Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Renal Cell CarcinomaRecruiting
Est. primary completion 2028-06-15 · NCT05327686 · CT.gov ↗
What to watch
Phase 1Sarcoma, HER-2 Protein Overexpression, Osteosarcoma, Rhabdomyosarcoma, Ewing Sarcoma, Synovial Sarcoma, Soft Tissue Sarcoma …Recruiting
Est. primary completion 2028-06-30 · NCT04995003 · CT.gov ↗
What to watch
Phase 1Glioblastoma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent Grade III Glioma, Grade III GliomaActive not recruiting
Est. primary completion 2028-06-30 · NCT04323046 · CT.gov ↗
What to watch
Phase 2Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Neoplasm, Lung Non-Small Cell Squamous Carcinoma …Active not recruiting
Est. primary completion 2028-06-30 · NCT03110978 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma of Head and NeckRecruiting
Est. primary completion 2028-06-30 · NCT05317000 · CT.gov ↗
What to watch
Phase 2Down Syndrome, Recurrent B Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2028-06-30 · NCT04546399 · CT.gov ↗
What to watch
July 2028 (6)
Phase 4Oncology, Infusion ReactionRecruiting
Est. primary completion 2028-07 · NCT06031233 · CT.gov ↗
What to watch
Phase 1Muscle Invasive Bladder Urothelial CarcinomaEnrolling by invitation
Est. primary completion 2028-07-01 · NCT06204614 · CT.gov ↗
What to watch
Phase 2Advanced Glioblastoma, Metastatic Melanoma in the Central Nervous System, MGMT-Unmethylated GlioblastomaRecruiting
Est. primary completion 2028-07-30 · NCT05909618 · CT.gov ↗
What to watch
Phase 1Gastric Cancer, Esophageal Cancer, Stomach Cancer, Esophagus Cancer, Gastroesophageal Junction CancerRecruiting
Est. primary completion 2028-07-31 · NCT05187182 · CT.gov ↗
What to watch
Phase 1/2Unresectable Cutaneous MelanomaNot yet recruiting
Est. primary completion 2028-07-31 · NCT07631325 · CT.gov ↗
What to watch
Phase 2Melanoma (Skin)Recruiting
Est. primary completion 2028-07-31 · NCT05704647 · CT.gov ↗
What to watch
August 2028 (3)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-08-15 · NCT07420439 · CT.gov ↗
What to watch
Phase 2Solid TumorsRecruiting
Est. primary completion 2028-08-15 · NCT07492680 · CT.gov ↗
What to watch
Phase 1Advanced Clear Cell Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma …Recruiting
Est. primary completion 2028-08-25 · NCT07128680 · CT.gov ↗
What to watch
September 2028 (2)
October 2028 (2)
Phase 4Renal Cell Carcinoma (Kidney Cancer), Metastatic Renal Cell Carcinoma, Locally AdvancedRecruiting
Est. primary completion 2028-10 · NCT07028125 · CT.gov ↗
What to watch
Early phase / not applicableMetastatic Renal Cell Carcinoma ( mRCC)Not yet recruiting
Est. primary completion 2028-10-01 · NCT07233668 · CT.gov ↗
What to watch
November 2028 (4)
Phase 2Locally Advanced Solid TumorRecruiting
Est. primary completion 2028-11 · NCT06534190 · CT.gov ↗
What to watch
Phase 2Melanoma Stage III, Melanoma Stage IV, Advanced Melanoma, MelanomaRecruiting
Est. primary completion 2028-11 · NCT06295159 · CT.gov ↗
What to watch
Early phase / not applicableMelanoma, Lung Cancer, Renal CancerRecruiting
Est. primary completion 2028-11-05 · NCT04605146 · CT.gov ↗
What to watch
Phase 3Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma …Recruiting
Est. primary completion 2028-11-08 · NCT05677490 · CT.gov ↗
What to watch
December 2028 (8)
Phase 1/2Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, CancerRecruiting
Est. primary completion 2028-12 · NCT03686124 · CT.gov ↗
What to watch
Phase 1/2Low Grade Glioma, High Grade GliomaRecruiting
Est. primary completion 2028-12 · NCT06712875 · CT.gov ↗
What to watch
Phase 2Advanced Microsatellite Stable Colorectal CancerRecruiting
Est. primary completion 2028-12 · NCT07527858 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal CancerNot yet recruiting
Est. primary completion 2028-12 · NCT07645118 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2028-12 · NCT06941857 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8Recruiting
Est. primary completion 2028-12-01 · NCT07226856 · CT.gov ↗
What to watch
Phase 2Renal Cell Carcinoma, Clear CellActive not recruiting
Est. primary completion 2028-12-15 · NCT06708949 · CT.gov ↗
What to watch
Phase 1B-Cell Non-Hodgkin Lymphoma, Histiocytic and Dendritic Cell Neoplasm, Myelodysplastic Syndrome …Recruiting
Est. primary completion 2028-12-31 · NCT03017820 · CT.gov ↗
What to watch
2029 (37)
January 2029 (3)
Phase 1/2HIV I InfectionRecruiting
Est. primary completion 2029-01 · NCT05187429 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2029-01-04 · NCT06697197 · CT.gov ↗
What to watch
Phase 2Rhabdoid TumorRecruiting
Est. primary completion 2029-01-31 · NCT06622941 · CT.gov ↗
What to watch
February 2029 (1)
Phase 2Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer, Cutaneous Squamous Cell Carcinoma of the Head and Neck …Recruiting
Est. primary completion 2029-02 · NCT06823479 · CT.gov ↗
What to watch
March 2029 (5)
Phase 2Melanoma (Skin Cancer), Melanoma Stage Stage IIIB, Melanoma Stage M1, Melanoma Stage IVRecruiting
Est. primary completion 2029-03 · NCT07740941 · CT.gov ↗
What to watch
Phase 1Fibrolamellar Hepatocellular Carcinoma (FLC)Recruiting
Est. primary completion 2029-03-01 · NCT04248569 · CT.gov ↗
What to watch
Phase 3Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8Recruiting
Est. primary completion 2029-03-10 · NCT07166406 · CT.gov ↗
What to watch
Phase 2Advanced Lung Adenocarcinoma, Refractory Lung Adenocarcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2029-03-17 · NCT06495125 · CT.gov ↗
What to watch
Phase 2/3Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin LymphomaNot yet recruiting
Est. primary completion 2029-03-31 · NCT07572123 · CT.gov ↗
What to watch
April 2029 (4)
Phase 1Diffuse Pleural Mesothelioma, Gastroesophageal Carcinoma, Urothelial CarcinomaRecruiting
Est. primary completion 2029-04 · NCT07532902 · CT.gov ↗
What to watch
Phase 3Primary Mediastinal LymphomaRecruiting
Est. primary completion 2029-04-01 · NCT06188676 · CT.gov ↗
What to watch
Phase 2Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8Recruiting
Est. primary completion 2029-04-30 · NCT06029270 · CT.gov ↗
What to watch
Phase 3Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2029-04-30 · NCT06632327 · CT.gov ↗
What to watch
May 2029 (4)
Phase 2Hodgkin LymphomaRecruiting
Est. primary completion 2029-05 · NCT06812858 · CT.gov ↗
What to watch
Phase 2Metastatic Melanoma, Advanced MelanomaRecruiting
Est. primary completion 2029-05 · NCT07504796 · CT.gov ↗
What to watch
Phase 2Adenocarcinoma of the Esophagogastric Junction, Perioperative PeriodActive not recruiting
Est. primary completion 2029-05-01 · NCT06681298 · CT.gov ↗
What to watch
Phase 4Unresectable Melanoma, Metastatic MelanomaNot yet recruiting
Est. primary completion 2029-05-26 · NCT07459543 · CT.gov ↗
What to watch
June 2029 (3)
Phase 1Uveal MelanomaRecruiting
Est. primary completion 2029-06-01 · NCT07501117 · CT.gov ↗
What to watch
Phase 2Newly Diagnosed GlioblastomaRecruiting
Est. primary completion 2029-06-01 · NCT06816927 · CT.gov ↗
What to watch
Phase 2Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder, Disorders, LymphoproliferativeRecruiting
Est. primary completion 2029-06-01 · NCT03258567 · CT.gov ↗
What to watch
July 2029 (3)
Phase 2Anaplastic Large Cell Lymphoma, ALK-PositiveRecruiting
Est. primary completion 2029-07-01 · NCT07013565 · CT.gov ↗
What to watch
Phase 2Richter's TransformationRecruiting
Est. primary completion 2029-07-31 · NCT06936943 · CT.gov ↗
What to watch
August 2029 (5)
Phase 2Breast Cancer, Leptomeningeal DiseaseRecruiting
Est. primary completion 2029-08 · NCT07694986 · CT.gov ↗
What to watch
Phase 3Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal CancerRecruiting
Est. primary completion 2029-08-16 · NCT07431281 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2029-08-31 · NCT03228667 · CT.gov ↗
What to watch
Phase 2Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 …Not yet recruiting
Est. primary completion 2029-08-31 · NCT07576725 · CT.gov ↗
What to watch
September 2029 (5)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-09 · NCT07563738 · CT.gov ↗
What to watch
Phase 1/2Vulvar Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2029-09 · NCT07679841 · CT.gov ↗
What to watch
Phase 2Unresectable or Metastatic Hepatocellular Carcinoma, Child-Pugh A Hepatocellular Carcinoma …Recruiting
Est. primary completion 2029-09 · NCT07219459 · CT.gov ↗
What to watch
Phase 1/2Primary Mediastinal (Thymic) Large B-cell Lymphoma, Children, NivolumabEnrolling by invitation
Est. primary completion 2029-09-01 · NCT06871007 · CT.gov ↗
What to watch
Phase 2HIV-1Not yet recruiting
Est. primary completion 2029-09-15 · NCT07820813 · CT.gov ↗
What to watch
October 2029 (2)
November 2029 (1)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-11-02 · NCT04665206 · CT.gov ↗
What to watch
December 2029 (1)
Phase 2Endometrial Neoplasms, Endometrial CancerRecruiting
Est. primary completion 2029-12 · NCT05795244 · CT.gov ↗
What to watch
2030 (33)
January 2030 (4)
Phase 2HER2-negative, Gastroesophageal Junction, Esophageal Adenocarcinoma, Gastric AdenocarcinomaRecruiting
Est. primary completion 2030-01 · NCT07546812 · CT.gov ↗
What to watch
Phase 2/3Metastatic Uveal MelanomaRecruiting
Est. primary completion 2030-01 · NCT06581406 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-01-31 · NCT07718243 · CT.gov ↗
What to watch
Phase 3Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2030-01-31 · NCT03811015 · CT.gov ↗
What to watch
March 2030 (3)
Phase 2Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal AdenocarcinomaRecruiting
Est. primary completion 2030-03 · NCT07432295 · CT.gov ↗
What to watch
Phase 1Brain Cancer, HGG, Glioma, High Grade Glioma, High Grade Gliomas, High Grade Glioma (III or IV) …Recruiting
Est. primary completion 2030-03-30 · NCT07210632 · CT.gov ↗
What to watch
Phase 2Lung Cancer - Non Small CellRecruiting
Est. primary completion 2030-03-31 · NCT06926790 · CT.gov ↗
What to watch
April 2030 (3)
Phase 1Hnscc, Head and Neck, Squamous Cell Cancer, Squamous Carcinoma, Squamous Cell Cancer of Head and Neck (SCCHN) …Recruiting
Est. primary completion 2030-04 · NCT07460765 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma of Head and Neck (SCCHN)Not yet recruiting
Est. primary completion 2030-04 · NCT07529873 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2030-04-01 · NCT04564157 · CT.gov ↗
What to watch
May 2030 (1)
Phase 3Cancer, Renal Cell Carcinoma (RCC), Pancreatic Neuroendocrine Tumors (pNET), Extra-Pancreatic NET (epNET), Hepatocellular Carcinoma (HCC) …Enrolling by invitation
Est. primary completion 2030-05-31 · NCT07620574 · CT.gov ↗
What to watch
June 2030 (2)
July 2030 (1)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-07-30 · NCT06561386 · CT.gov ↗
What to watch
August 2030 (1)
September 2030 (4)
Phase 1Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))Not yet recruiting
Est. primary completion 2030-09 · NCT07430202 · CT.gov ↗
What to watch
Phase 3High-risk MelanomaRecruiting
Est. primary completion 2030-09 · NCT06488482 · CT.gov ↗
What to watch
Phase 2/3Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma …Recruiting
Est. primary completion 2030-09-02 · NCT05987241 · CT.gov ↗
What to watch
Phase 3Advanced MelanomaRecruiting
Est. primary completion 2030-09-30 · NCT06264180 · CT.gov ↗
What to watch
October 2030 (1)
Phase 1Prostate Cancer Patients, Non-castrate Prostate Cancer, Recurrent Prostate Cancer, Oligometastatic Prostate Cancer (OMPC)Recruiting
Est. primary completion 2030-10 · NCT07090148 · CT.gov ↗
What to watch
November 2030 (2)
Phase 2/3Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaRecruiting
Est. primary completion 2030-11-08 · NCT07221149 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-11-30 · NCT07223424 · CT.gov ↗
What to watch
December 2030 (11)
Phase 1Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas, Medulloblastoma Recurrent, Ependymoma Recurrent …Recruiting
Est. primary completion 2030-12 · NCT07664176 · CT.gov ↗
What to watch
Phase 1Recurrent High-grade Glioma, Grade III Astrocytoma, Oligodendroglioma, Oligoastrocytoma, Ependymoma, Grade IV AstrocytomaActive not recruiting
Est. primary completion 2030-12 · NCT07031765 · CT.gov ↗
What to watch
Phase 1/2Metastatic Triple-negative Breast CancerRecruiting
Est. primary completion 2030-12 · NCT06963905 · CT.gov ↗
What to watch
Phase 1/2Metastatic Melanoma, Liver MetastasesRecruiting
Est. primary completion 2030-12 · NCT07281924 · CT.gov ↗
What to watch
Phase 1Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IVRecruiting
Est. primary completion 2030-12-02 · NCT07328087 · CT.gov ↗
What to watch
Phase 2/3Lung Adenocarcinoma, Lung Adenosquamous Carcinoma, Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2030-12-12 · NCT04929041 · CT.gov ↗
What to watch
Phase 1/2Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue SarcomaRecruiting
Est. primary completion 2030-12-31 · NCT03138161 · CT.gov ↗
What to watch
Phase 2LOCALLY ADVANCED CERVICAL CANCERSActive not recruiting
Est. primary completion 2030-12-31 · NCT06715241 · CT.gov ↗
What to watch
Phase 2Hodgkin LymphomaRecruiting
Est. primary completion 2030-12-31 · NCT07551583 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-12-31 · NCT07050043 · CT.gov ↗
What to watch
2031 (13)
January 2031 (1)
Phase 2Breast CancerRecruiting
Est. primary completion 2031-01-01 · NCT03815890 · CT.gov ↗
What to watch
February 2031 (2)
April 2031 (2)
August 2031 (2)
Phase 1/2Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Sarcomatoid Renal Cell Carcinoma …Recruiting
Est. primary completion 2031-08-01 · NCT06866262 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2031-08-31 · NCT04895709 · CT.gov ↗
What to watch
September 2031 (2)
Phase 2AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2031-09-15 · NCT04929028 · CT.gov ↗
What to watch
Phase 1HNSCC, SCC - Squamous Cell Carcinoma, Oral CancerNot yet recruiting
Est. primary completion 2031-09-30 · NCT07741565 · CT.gov ↗
What to watch
October 2031 (1)
Phase 2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2031-10-31 · NCT07689175 · CT.gov ↗
What to watch
December 2031 (3)
Phase 3Advanced Kidney CancerNot yet recruiting
Est. primary completion 2031-12 · NCT07338981 · CT.gov ↗
What to watch
Phase 1Soft Tissue SarcomasRecruiting
Est. primary completion 2031-12-31 · NCT07444619 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer (MSI-H)Not yet recruiting
Est. primary completion 2031-12-31 · NCT07403877 · CT.gov ↗
What to watch
2032 (9)
January 2032 (1)
Phase 2Advanced Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 …Recruiting
Est. primary completion 2032-01-03 · NCT06745076 · CT.gov ↗
What to watch
February 2032 (1)
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2032-02-18 · NCT05533697 · CT.gov ↗
What to watch
March 2032 (1)
Phase 2Colon CarcinomaRecruiting
Est. primary completion 2032-03-01 · NCT03026140 · CT.gov ↗
What to watch
April 2032 (2)
May 2032 (2)
July 2032 (2)
Phase 2Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma …Recruiting
Est. primary completion 2032-07-30 · NCT05112601 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2032-07-31 · NCT07355205 · CT.gov ↗
What to watch
2033 (4)
January 2033 (1)
Phase 3Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 …Recruiting
Est. primary completion 2033-01-31 · NCT07383441 · CT.gov ↗
What to watch
March 2033 (1)
Phase 2High Grade Glioma, Diffuse Intrinsic Pontine Glioma, WHO Grade 3 Glioma, WHO Grade 4 Glioma, Replication Repair DeficientNot yet recruiting
Est. primary completion 2033-03-01 · NCT07644312 · CT.gov ↗
What to watch
June 2033 (1)
Phase 2/3Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7Active not recruiting
Est. primary completion 2033-06-30 · NCT02339571 · CT.gov ↗
What to watch
August 2033 (1)
Phase 2Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 …Recruiting
Est. primary completion 2033-08-01 · NCT07510334 · CT.gov ↗
What to watch
2034 (1)
April 2034 (1)
Phase 3Von Hippel-Lindau Disease, Malignant NeoplasmsRecruiting
Est. primary completion 2034-04-22 · NCT07405164 · CT.gov ↗
What to watch
2040 (1)
February 2040 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2040-02-28 · NCT07770100 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.